Endothelial function testing as a biomarker of vascular disease.
By S. Verma, M. Buchanan, T. Anderson. Circulation, 2003
607 citations recorded by the source corpus.
Subfields: Cancer Research, Cardiology and Cardiovascular Medicine, Immunology
View Paper: https://www.semanticscholar.org/paper/872cf2e35ba78b7a80f1959d75372d44567b83ca
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- L. Shaw
- C. Merz
- C. Pepine
- R. Cooper-DeHoff
- S. Jebari-Benslaiman
- B. Johnson
- E. Handberg
- H. Black
Citations in the corpus
- Pathophysiology of Atherosclerosis (2022, background): “Briefly, when ECs lose their ability to maintain homeostasis, vessel walls are predisposed to vasoconstriction, lipid infiltration, leukocyte adhesion, platelet activation, and oxidative stress, among other things [23,24].”
- Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. (2009, background): “It has been hypothesized that this abnormal endothelial response may be the earliest marker of vascular disease, representing a critical step in atherosclerosis.(29,30) The mechanism of this impaired endothelial response appears to be due to imbalance between endotheliumderived vasodilators that hav”